<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 3: Chronic Inflammation: The Silent Driver of Pathology | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 list-style: none;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 position: relative;
 padding-left: 25px;
}
.takeaways-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #B8860B;
}

/* REFERENCES BOX */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 10px;
}

.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
}

.stat-highlight {
 font-weight: 800;
 color: #722F37;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 12: Functional Immunology and Immune Dysregulation</span>
 <h1 class="lesson-title">Chronic Inflammation: The Silent Driver of Pathology</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">üéì Lesson 3 of 8</span>
 <span class="meta-badge">üõ°Ô∏è Level: Advanced</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Excellence</div>
 <div class="title">AccrediPro Standards Institute Certified Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">Lesson Architecture</span>
 <ul class="toc-list">
 <li><a href="#smoldering"><span class="section-num">01</span>Smoldering vs. Storming</a></li>
 <li><a href="#nfk-b"><span class="section-num">02</span>The NF-Œ∫B Master Switch</a></li>
 <li><a href="#redox"><span class="section-num">03</span>The Redox-Immune Crosstalk</a></li>
 <li><a href="#biomarkers"><span class="section-num">04</span>Clinical Biomarkers</a></li>
 <li><a href="#resolution"><span class="section-num">05</span>Lipoxins & Resolvins</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>Building Your Clinical Lens:</strong> In Lesson 2, we explored how barrier integrity in the gut dictates immune "education." Today, we examine what happens when that education fails, leading to <span class="highlight">chronic systemic low-grade inflammation (SLAI)</span>‚Äîthe mechanism behind nearly every chronic disease you will encounter as a practitioner.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>The "Invisible" Threat</h3>
 <p>Welcome back, Practitioner. If acute inflammation is a controlled burn designed to clear brush, chronic inflammation is a <span class="highlight">smoldering fire</span> beneath the floorboards of the house. It is often asymptomatic until significant tissue damage has occurred. In this lesson, we will move beyond the surface to understand the molecular "master switches" that keep your clients stuck in a pro-inflammatory state.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Differentiate between the acute 'Cytokine Storm' and chronic low-grade systemic inflammation.</li>
 <li>Identify the NF-Œ∫B pathway as the master switch for pro-inflammatory gene expression.</li>
 <li>Explain the synergistic relationship between oxidative stress and immune-mediated tissue damage.</li>
 <li>Interpret hs-CRP, ESR, and Ferritin using functional ranges vs. conventional "normal" ranges.</li>
 <li>Analyze the role of specialized pro-resolving mediators (SPMs) in the resolution of inflammation.</li>
 </ul>
 </div>

 <h2 id="smoldering">Smoldering vs. Storming: The Spectrum of Inflammation</h2>
 <p>In conventional medicine, inflammation is often viewed as a binary state: it is either present (acute infection, trauma) or absent. However, functional medicine recognizes a <span class="highlight">spectrum of immune activation</span>. On one end, we have the "Cytokine Storm"‚Äîa hyper-acute, life-threatening release of pro-inflammatory cytokines (IL-1, IL-6, TNF-Œ±) often seen in sepsis or severe viral infections.</p>

 <p>On the other end, and far more common in your practice, is <strong>Chronic Low-Grade Systemic Inflammation (CLGI)</strong>. CLGI is characterized by a 2- to 4-fold increase in circulating levels of pro-inflammatory cytokines. While this may not cause a fever, it acts as a "silent driver," slowly degrading mitochondrial function, insulin sensitivity, and vascular health.</p>

 <div class="coach-tip">
 <span class="tip-label">Practitioner Insight</span>
 <p>üí° Many of your clients‚Äîespecially women in their 40s and 50s‚Äîmay be told their "labs are normal" while they suffer from brain fog and joint pain. This is because conventional ranges for CRP often only flag risk at >3.0 mg/L, but in functional medicine, we begin investigating at <span class="highlight">>1.0 mg/L</span>. Catching CLGI early can save your clients years of future pathology.</p>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë§</div>
 <div>
 <p class="title">Clinical Case: Sarah's "Unexplained" Fatigue</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <div>
 <p><strong>Client:</strong> Sarah, 48, High School Principal</p>
 <p><strong>Symptoms:</strong> Persistent fatigue, "morning stiffness," and difficulty losing weight despite a calorie deficit.</p>
 <p><strong>The "Reveal":</strong> Conventional labs showed a TSH of 2.4 (Normal) and a Glucose of 98 (Normal). However, functional analysis revealed an <strong>hs-CRP of 2.8 mg/L</strong> and a <strong>Ferritin of 210 ng/mL</strong>.</p>
 </div>
 </div>
 <p>Sarah wasn't "lazy" or "aging poorly." She was in a state of smoldering inflammation. By identifying her root trigger (latent gut dysbiosis and high perceived stress), we lowered her CRP to 0.5 mg/L. Outcome: Her energy returned, and she lost 12 lbs in 8 weeks without changing her exercise routine. This is the power of addressing the <em>driver</em> rather than the <em>symptom</em>.</p>
 </div>
 </div>

 <h2 id="nfk-b">NF-Œ∫B: The Master Switch of Inflammation</h2>
 <p>To truly target inflammation, we must understand <strong>Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-Œ∫B)</strong>. Think of NF-Œ∫B as the "General" in the command center of the cell. When it is activated by triggers‚Äîsuch as LPS from a leaky gut, environmental toxins, or high cortisol‚Äîit moves into the nucleus and flips the switch on over 200 pro-inflammatory genes.</p>

 <p>Chronic activation of NF-Œ∫B leads to:</p>
 <ul>
 <li><strong>Cytokine Production:</strong> Continuous release of TNF-Œ± and IL-6.</li>
 <li><strong>Adhesion Molecules:</strong> Making blood vessels "sticky," contributing to atherosclerosis.</li>
 <li><strong>Enzyme Activation:</strong> Upregulation of COX-2 (the target of NSAIDs like Ibuprofen).</li>
 </ul>

 <p>In Functional Medicine, we don't just want to "block" NF-Œ∫B with drugs; we want to <strong>modulate</strong> it by removing the triggers that keep the General in "combat mode." This is a core component of the <span class="highlight">Target phase</span> of the R.O.O.T.S. Method‚Ñ¢.</p>

 <h2 id="redox">The Redox-Immune Crosstalk</h2>
 <p>Recall from Module 8 our deep dive into oxidative stress. There is a "vicious cycle" between oxidative stress and immune dysregulation. When immune cells (like macrophages) are activated, they produce <strong>Reactive Oxygen Species (ROS)</strong> to kill pathogens. However, in chronic inflammation, these ROS spill out and damage healthy neighboring cells.</p>

 <p>This damage creates "DAMPs" (Damage-Associated Molecular Patterns). The immune system sees these DAMPs as a sign of further danger, which triggers <em>more</em> NF-Œ∫B activation, creating a <span class="highlight">self-perpetuating loop of tissue destruction</span>. This is why you cannot fix the immune system without also addressing mitochondrial health and antioxidant status.</p>

 <h2 id="biomarkers">Clinical Biomarkers: Reading the Smoke Signals</h2>
 <p>Interpreting inflammation requires looking at multiple markers to see the "total picture." A single elevated marker might be a fluke; three elevated markers are a pattern.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Biomarker</th>
 <th>Conventional "Normal"</th>
 <th>Functional Optimal</th>
 <th>Clinical Significance</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>hs-CRP</strong></td>
 <td>< 3.0 mg/L</td>
 <td><strong>< 1.0 mg/L</strong></td>
 <td>Systemic inflammation; cardiovascular risk.</td>
 </tr>
 <tr>
 <td><strong>ESR (Sed Rate)</strong></td>
 <td>0 - 20 mm/hr</td>
 <td><strong>< 10 mm/hr</strong></td>
 <td>"Heavy" blood; slower response marker of inflammation.</td>
 </tr>
 <tr>
 <td><strong>Ferritin</strong></td>
 <td>15 - 150 ng/mL</td>
 <td><strong>40 - 100 ng/mL</strong></td>
 <td>Acute phase reactant; high levels suggest "hidden" inflammation.</td>
 </tr>
 <tr>
 <td><strong>Fibrinogen</strong></td>
 <td>200 - 400 mg/dL</td>
 <td><strong>225 - 300 mg/dL</strong></td>
 <td>Clotting risk and vascular inflammation.</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Income Opportunity</span>
 <p>üí° Practitioners who specialize in "Inflammation Mapping" often command higher fees. By explaining these nuances to a client, you move from being a "wellness coach" to a <span class="highlight">Clinical Strategist</span>. A comprehensive functional blood chemistry analysis can be a $500 - $997 standalone service in a successful practice.</p>
 </div>

 <h2 id="resolution">The Resolution Phase: Lipoxins and Resolvins</h2>
 <p>Perhaps the most exciting frontier in functional immunology is the concept of <strong>Resolution</strong>. For decades, we thought inflammation just "faded away." We now know that the body must <em>actively</em> turn inflammation off through the production of <strong>Specialized Pro-resolving Mediators (SPMs)</strong>, such as Lipoxins, Resolvins, and Protectins.</p>

 <p>SPMs are derived from Omega-3 fatty acids (EPA and DHA). They do not suppress the immune system (like steroids do); instead, they "clean up the battlefield" by:</p>
 <ul>
 <li>Stopping the recruitment of more neutrophils.</li>
 <li>Encouraging macrophages to eat cell debris (efferocytosis).</li>
 <li>Promoting tissue regeneration.</li>
 </ul>

 <p>If your client has low Omega-3 levels or high oxidative stress, they may lack the "brakes" to stop the inflammatory process, leading to <span class="highlight">chronic unresolved inflammation</span>.</p>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why is CLGI (Chronic Low-Grade Inflammation) often missed in conventional medicine?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Reveal Answer</button>
 <div id="ans1" class="answer-text">
 CLGI is missed because it often falls within the "normal" conventional reference range (e.g., a CRP of 2.5 mg/L), and it rarely causes acute symptoms like fever. However, functionally, these levels indicate a significant increase in risk for chronic disease.
 </div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the role of NF-Œ∫B in the inflammatory process?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Reveal Answer</button>
 <div id="ans2" class="answer-text">
 NF-Œ∫B acts as a "master switch" transcription factor. Once activated by triggers like toxins or LPS, it enters the cell nucleus and upregulates the expression of over 200 pro-inflammatory genes, including cytokines and enzymes like COX-2.
 </div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. How does oxidative stress contribute to chronic inflammation?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Reveal Answer</button>
 <div id="ans3" class="answer-text">
 Oxidative stress creates DAMPs (Damage-Associated Molecular Patterns) from damaged tissue. These DAMPs are recognized by the immune system as "danger signals," which further activates NF-Œ∫B and immune responses, creating a vicious cycle of damage and inflammation.
 </div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. What are Resolvins and why are they clinically significant?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Reveal Answer</button>
 <div id="ans4" class="answer-text">
 Resolvins are Specialized Pro-resolving Mediators (SPMs) derived from Omega-3s. They are significant because they actively "turn off" the inflammatory response and promote tissue healing, rather than simply suppressing the immune system.
 </div>
 </div>
 </div>

 <!-- Takeaways Box -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways for the Practitioner</p>
 <ul>
 <li><strong>Inflammation is a Spectrum:</strong> Always look for "smoldering" low-grade inflammation, even when acute symptoms are absent.</li>
 <li><strong>Master the Switch:</strong> NF-Œ∫B is the primary target for modulation; focus on removing triggers (LPS, toxins, stress) to "quiet" the General.</li>
 <li><strong>Functional Ranges Matter:</strong> Aim for an hs-CRP < 1.0 mg/L for true metabolic and cardiovascular resilience.</li>
 <li><strong>Resolution is Active:</strong> Ensure adequate Omega-3 status to provide the raw materials for Resolvins and Lipoxins to end the inflammatory cycle.</li>
 <li><strong>The Redox Connection:</strong> You cannot resolve immune dysregulation without simultaneously addressing oxidative stress and mitochondrial health.</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Furman, D. et al. (2019). "Chronic inflammation in the etiology of disease across the life span." <em>Nature Medicine</em>.</li>
 <li>Serhan, C. N. (2014). "Pro-resolving lipid mediators are leads for resolution physiology." <em>Nature</em>.</li>
 <li>Calder, P. C. (2017). "Omega-3 fatty acids and inflammatory processes: from molecules to man." <em>Biochemical Society Transactions</em>.</li>
 <li>Liu, T. et al. (2017). "NF-Œ∫B signaling in inflammation." <em>Signal Transduction and Targeted Therapy</em>.</li>
 <li>Minihane, A. M. et al. (2015). "Low-grade inflammation, diet composition and health: current research protocols and endpoints." <em>British Journal of Nutrition</em>.</li>
 <li>Hotamisligil, G. S. (2017). "Inflammation, metaflammation and immunometabolic disorders." <em>Nature</em>.</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}

// Standardized listener for any reveal-btn or reveal-button classes
document.querySelectorAll('.reveal-btn, .reveal-button').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && (answer.classList.contains('answer-text') || answer.classList.contains('reveal-answer'))) {
 // The onclick above handles display, but this ensures compatibility
 // answer.classList.toggle('show'); 
 }
 });
});
</script>
</body>
</html>